Mota SI, Pita I, guas R, Tagorti S, Virmani A, Pereira FC, Rego AC (2021) Mechanistic perspectives on differential mitochondrial-based neuroprotective effects of several carnitine forms in Alzheimers disease in vitro model
# FDA Removes 12 Peptides from Category 2 Restrictions: What Changed in April 2026 In April 2026, the FDA announced it would remove 12 popular peptides from Category 2 restrictions including some of the most widely used compounds in biohacking, regenerative medicine, and peptide therapy circles
Q5: Do I need a deficiency to benefit from B12
Most glutathione supplements do not fix this because they never actually reach your cells
KPV is a potent general anti-inflammatory, but its true benefit is in its ability to reduce intestinal inflammation in mouse models of inflammatory bowel disease